Filing Details
- Accession Number:
- 0001209191-20-031059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-20 20:02:28
- Reporting Period:
- 2020-05-18
- Accepted Time:
- 2020-05-20 20:02:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1631320 | Jr. Donald Michael Abney | 9975 Summers Ridge Road San Diego CA 92121 | Svp - Distribution | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-18 | 8,798 | $15.40 | 15,432 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-18 | 8,798 | $198.12 | 6,634 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-05-18 | 7,172 | $21.08 | 13,806 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-18 | 7,172 | $198.87 | 6,634 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option | Disposition | 2020-05-18 | 8,798 | $0.00 | 8,798 | $15.40 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2020-05-18 | 7,172 | $0.00 | 7,172 | $21.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-10 | No | 4 | M | Direct | |
| 7,171 | 2027-02-15 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $198.1224 per share, with a range of $193.13 to $201.97. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $198.8715 per share, with a range of $196.035 to $201.97. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- 17,596 shares vested on the second anniversary date of the grant date, February 10, 2018. 8.798 shares vested on the third anniversary date of the grant date, February 10, 2019. 8,798 shares vested on the fourth anniversary date of the grant date, February 10, 2020.
- 7,172 shares vested on the second anniversary date of the grant date, February 15, 2019. 3,586 shares vested on the third anniversary date of the grant date, February 15, 2020. 3,585 shares will vest on the fourth anniversary date of the grant date, February 15, 2021.
Billionaire Hedge Funds
